(Q54663296)

English

A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Cryptococcus neoformans

1 reference

based on heuristic

inferred from title

author name string

Burgess DS

1

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

Hastings RW

2

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

38

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

2

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

87-93

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of pharmacokinetics in the outcome of infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of fungal infection in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cryptococcal meningitis and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances in the management of cryptococcal meningitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of amphotericin B-resistant Candida isolates in a broth-based system

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Role for Dual Individualization with Cefmenoxime

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antibiotic carry-over on bacterial counting by ‘spiral plating’

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900173-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(00)00173-5

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/11035239

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54663296&oldid=1588019037"